| 000 | 01532 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513051830.0 | ||
| 264 | 0 | _c19941028 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1038/clpt.1994.135 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTurgeon, D K | |
| 245 | 0 | 0 |
_aP450 3A activity and cyclosporine dosing in kidney and heart transplant recipients. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cSep 1994 |
||
| 300 |
_a253-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBreath Tests _xmethods |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2E1 |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aErythromycin |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeart Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xmetabolism |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRegression Analysis |
| 700 | 1 | _aLeichtman, A B | |
| 700 | 1 | _aLown, K S | |
| 700 | 1 | _aNormolle, D P | |
| 700 | 1 | _aDeeb, G M | |
| 700 | 1 | _aMerion, R M | |
| 700 | 1 | _aWatkins, P B | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 56 _gno. 3 _gp. 253-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.1994.135 _zAvailable from publisher's website |
| 999 |
_c7923451 _d7923451 |
||